Spots Global Cancer Trial Database for inoperable disease
Every month we try and update this database with for inoperable disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | NCT04562129 | Melanoma Stage ... Melanoma Stage ... Inoperable Dise... | Interleukin-2 Ipilimumab Nivolumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients. | NCT04652206 | Metastatic Panc... Locally Advance... Inoperable Dise... Localized Pancr... | SCO-101 Gemcitabine Nab paclitaxel | 18 Years - | Scandion Oncology A/S | |
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | NCT04562129 | Melanoma Stage ... Melanoma Stage ... Inoperable Dise... | Interleukin-2 Ipilimumab Nivolumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
CH-EUS in Diagnosis of Inoperable Bile Duct Tumors | NCT05418543 | Inoperable Dise... Bile Duct Cance... | Endoscopic ultr... | 18 Years - 99 Years | Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor | |
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer | NCT04360941 | Triple Negative... Locally Advance... Recurrent Breas... Metastatic Brea... ER+ Breast Canc... HER2-positive B... | Palbociclib Avelumab | 18 Years - | Royal Marsden NHS Foundation Trust | |
Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients. | NCT04652206 | Metastatic Panc... Locally Advance... Inoperable Dise... Localized Pancr... | SCO-101 Gemcitabine Nab paclitaxel | 18 Years - | Scandion Oncology A/S | |
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | NCT04562129 | Melanoma Stage ... Melanoma Stage ... Inoperable Dise... | Interleukin-2 Ipilimumab Nivolumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
CH-EUS in Diagnosis of Inoperable Bile Duct Tumors | NCT05418543 | Inoperable Dise... Bile Duct Cance... | Endoscopic ultr... | 18 Years - 99 Years | Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor |